The University of Iowa
The University of Iowa News Services Home News Releases UI in the News Subscribe to UI News Contact Us


8788 John Pappajohn Pavilion
Iowa City IA 52242
(319) 356-8981

Release: Nov. 17, 2000

Gingrich named associate director for clinical services at UI's Holden Cancer Center

IOWA CITY, Iowa -- Officials with the Holden Cancer Center at the University of Iowa today announced the appointment of Roger Gingrich, M.D., Ph.D., as the center's associate director for clinical services.

George Weiner, M.D., director of the Holden Cancer Center, created the new associate director position in order to coordinate the interactions between the Holden Cancer Center and referring physicians in the community. Gingrich will also oversee clinical activities in the John and Mary Pappajohn Clinical Cancer Center, the Cancer Information Service, and the Oncology Registry.

"My hope is to create an atmosphere where people who are clinically oriented -- either in education, research or patient care -- feel empowered to dream and brainstorm with each other about how this Cancer Center can become the best possible place for Iowans and others to come for cancer care," Gingrich said, "especially when those needs can't be met in their local communities."

"We are pleased that Dr. Gingrich accepted the associate director position," Weiner said in a letter to faculty and staff of University of Iowa Health Care. "In his current role as director of the Adult Bone Marrow Transplantation Program, he has gained extensive experience in the management of a complex clinical program, and he has developed outstanding relationships with community physicians."

"The possibilities for exploring and developing our cancer care to be the very best it can be are what attracted me to this position," Gingrich said. "There are three areas of development that will be my initial priorities. These include multidisciplinary oncology care, interaction with referring physicians who do oncology, and management of quality."

Gingrich pointed out that the Holden Cancer Center staff already provides high quality care, research and education but he sees potential for even greater achievements. Gingrich plans to meet with the clinical faculty and staff to discuss the progress of the Holden Cancer Center team in an open, collaborative, process-oriented forum. The goal is to evaluate the center's strengths and identify areas for improvement.

"We all know that we do a great job," Gingrich said. "but how do we measure that and improve on it? Without a doubt, all of what we do will require that we work as a team in successfully executing our mission."

Gingrich will offer his e-mail address as a suggestion box for faculty and staff to offer input about changes they'd like to see made and hopes they have for the future of the Holden Cancer Center.

Gingrich said he will continue in his current role as director of Adult Bone Marrow Transplantation, but will focus an increasing amount of his attention on his new position.

Last July, the Holden Cancer Center was awarded the prestigious National Cancer Institute seal of approval. This designation as an NCI Cancer Center places University of Iowa Health Care among the highest in the field. The Holden Cancer Center is the only NCI-designated center in Iowa, and one of only 33 in the United States.

University of Iowa Health Care describes the partnership between the UI College of Medicine and the UI Hospitals and Clinics and the patient care, medical education and research programs and services they provide.